Jinxin Fertility Group Ltd. said its Shenzhen Zhongshan Obstetrics and Gynecology Hospital’s new campus began trial operations on Feb. 6, 2026. The facility is located in central Shenzhen and has a gross floor area of 40,000 square meters, about four times the size of the original campus. The company reported that its Shenzhen operations recorded an 18% increase in oocyte pick up cycles in the first two months of 2026 compared with the same period in 2025. In the United States, HRC Fertility clinics controlled through management service agreements reported an approximately 38% increase in oocyte pick up cycles over the same period, which the company attributed primarily to increased local demand following the implementation of California’s IVF insurance coverage under Senate Bill 729 in January 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jinxin Fertility Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260304-12041299), on March 04, 2026, and is solely responsible for the information contained therein.
Comments